BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11238046)

  • 21. Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.
    Zhu X; Kanai Y; Saito A; Kondo Y; Hirohashi S
    Pathol Int; 2000 Dec; 50(12):945-52. PubMed ID: 11123760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
    Mirabelli-Primdahl L; Gryfe R; Kim H; Millar A; Luceri C; Dale D; Holowaty E; Bapat B; Gallinger S; Redston M
    Cancer Res; 1999 Jul; 59(14):3346-51. PubMed ID: 10416591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
    Gamallo C; Palacios J; Moreno G; Calvo de Mora J; Suárez A; Armas A
    Am J Pathol; 1999 Aug; 155(2):527-36. PubMed ID: 10433945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
    Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-catenin (Ctnnb1) gene mutations in diethylnitrosamine (DEN)-induced liver tumors in male F344 rats.
    Yamada Y; Yoshimi N; Sugie S; Suzui M; Matsunaga K; Kawabata K; Hara A; Mori H
    Jpn J Cancer Res; 1999 Aug; 90(8):824-8. PubMed ID: 10543253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
    Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
    Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas.
    Machin P; Catasus L; Pons C; Muñoz J; Matias-Guiu X; Prat J
    Hum Pathol; 2002 Feb; 33(2):206-12. PubMed ID: 11957146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequencing of the rat beta-catenin gene (Ctnnb1) and mutational analysis of liver tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline.
    Li Q; Dixon BM; Al-Fageeh M; Blum CA; Dashwood RH
    Gene; 2002 Jan; 283(1-2):255-62. PubMed ID: 11867232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
    Hao X; Frayling IM; Willcocks TC; Han W; Tomlinson IP; Pignatelli MN; Pretlow TP; Talbot IC
    Virchows Arch; 2002 Apr; 440(4):362-6. PubMed ID: 11956815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear β-catenin expression in basal cell adenomas of salivary gland.
    Kawahara A; Harada H; Abe H; Yamaguchi T; Taira T; Nakashima K; Mihashi H; Akiba J; Kage M
    J Oral Pathol Med; 2011 Jul; 40(6):460-6. PubMed ID: 21323741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.
    Nhieu JT; Renard CA; Wei Y; Cherqui D; Zafrani ES; Buendia MA
    Am J Pathol; 1999 Sep; 155(3):703-10. PubMed ID: 10487827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.
    Geyer FC; Lacroix-Triki M; Savage K; Arnedos M; Lambros MB; MacKay A; Natrajan R; Reis-Filho JS
    Mod Pathol; 2011 Feb; 24(2):209-31. PubMed ID: 21076461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of the beta-catenin gene in endometrial carcinomas.
    Kobayashi K; Sagae S; Nishioka Y; Tokino T; Kudo R
    Jpn J Cancer Res; 1999 Jan; 90(1):55-9. PubMed ID: 10076565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-catenin mutations in biliary tract cancers: a population-based study in China.
    Rashid A; Gao YT; Bhakta S; Shen MC; Wang BS; Deng J; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Apr; 61(8):3406-9. PubMed ID: 11309300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
    Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
    J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
    Palacios J; Gamallo C
    Cancer Res; 1998 Apr; 58(7):1344-7. PubMed ID: 9537226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.